Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019225 |
---|---|
Receipt number | R000022218 |
Scientific Title | A phase II study combining gemcitabine and carboplatin in patients with platinum-resistant ovarian cancer |
Date of disclosure of the study information | 2015/10/05 |
Last modified on | 2020/01/24 21:09:39 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/10/03 20:09:05 | ||
2 | Update | 2017/10/05 16:26:27 | Name of primary person or sponsor Organization |
|
3 | Update | 2018/07/24 14:21:03 | Recruitment status Last follow-up date |
|
4 | Update | 2020/01/24 21:09:39 | Recruitment status Date of IRB |